Population
Patients with acute myocardial infarction (AMI)
Design
Review
Authors
Loading...
Persistent microvascular impairment despite TIMI 3 flow warrants clinical caution; leaves open targeted adjunctive therapies for AMI.
Microvascular dysfunction remains a significant clinical challenge in up to 40% of AMI patients despite successful epicardial reperfusion.
Prasad et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: